Multiple Sclerosis News: Two Pharmaceutical Giants Will Work Together To Treat The Auto Immune Disease, Is This The Final Answer?
As of the present time, there is no known cure to Multiple sclerosis which has baffled experts ever since its emergence. However, that could possibly change in no time as two of the well-known pharmaceutical giants, Sanofi and ImmuNext have recently announced that they have finally come up to an agreement to develop an antibody with the potential to treat a series of autoimmune diseases, including multiple sclerosis (MS) and lupus. The two companies revealingly said that they are currently planning to launch a research collaboration that will allegedly support clinical testing of the drug that will hopefully shed light to the mysterious disease that continues to affect millions of people globally.
Two Pharmaceutical Giants Will Work Together To Treat Multiple Sclerosis
According to reports revealed by BioPharma Dive, the said agreement would be able to grant Sanofi with exclusive worldwide manufacturing and marketing rights to ImmuNext's preclinical drug INX-021, a monoclonal antibody that is known to calm a cellular pathway for a protein called CD40L or CD154. Experts believe that the protein has the ability to regulate the immune response and contribute to autoimmune diseases and chronic inflammation if by any chance that it becomes hyperactive. In return, it was found that the deal incorporates that Immunext could get up to $500 million in potential milestone payments, plus up to double-digit tiered royalties on product sales.
Meanwhile, in one of his statements reported by Multiple Sclerosis News Today, Randolph Noelle, PhD, co-founder and chief scientific officer of ImmuNext, said that the immune-regulatory molecule, CD40L, will allegedly play an important role in terms of the progression of a wide spectrum of autoimmune diseases. He adds that antibodies that blocks the function of CD40L have already been proven in pre-clinical models of autoimmunity to be one of the most effective agents in treating disease. Furthermore, authorities from the said agreement have also revealed that when it comes to the efficacy of the anti-CD40L for the treatment of autoimmune diseases, they believe that it has the ability to offer a unique opportunity to put the disease into silent progression and provide a long-term remission.
Everything You Need To Know About The 'Paleolithic Diet' And How It Can Beat Multiple Sclerosis: Is It The Final Answer?
Considering that Multiple Sclerosis is commonly dubbed as a lifestyle disease, can it also be beaten by following a certain lifestyle change in diet? Is Diet the solution for the mysterious emergence of Relapsing Remitting Multiple Sclerosis? Here's what health and nutrition experts have to say
Multiple Sclerosis Cure Finally Revealed As It Offers Hope With New Treatment Approach: Is There A Catch?
With the emergence of the mysterious disease, is the perfect solution finally found? What’s the truth behind claims that the cure for both Progressive and Relapsing Multiple Sclerosis is now here? Is there a catch to this so-called ‘cure’? Find out what health experts have to say
Everything You Have To Know About Progressive Multiple Sclerosis And Why It’s Currently The Talk Of The Town?
As Progressive Multiple Sclerosis is known as a mysterious disease, why is currently being put to the spotlight? Does it mean that the ‘cure’ is finally found, or more and more victims of the said medical condition are being recorded? Find out what health experts have to say
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
President Trump Nominates Conservative Physician, Scott Gottlieb, To Head the FDA
President Donald Trump has nominated Dr. Scott Gottlieb as potential had of the US Food and Drug Administration (FDA) agency. Gottlieb is regarded as a conservative physician and businessman with extensive experience of how the pharmaceutical industry is run. In fact, many voices in the health industry call for the US Senate to approve his nomination for the job.
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
MORE IN ITECHPOST
How to Protect Yourself on Facebook
Facebook is an application that takes on an all-encompassing role in our social media lives. It is a space where we communicate with friends and family about our personal lives, browse through an endless stream of content, and interact with other companies and entities on groups and pages.
How Do Personal Emergency Response Systems Work?
Personal emergency response systems, known as PERS for short, are systems that help people to raise the alarm and get immediate help when a medical or personal emergency occurs. They are ideal for older people and anyone with a mobility issue or an injury or illness that can cause falls.
The 9 Most Popular (And Fun) Internet Games of 2019
Are you bored of board games? What are the most popular internet games from this year? These nine are popular for a reason. Check 'em out!